Morgan Joseph downgrades Myriad Genetics, Inc. (Nasdaq: MYGN) from Buy to Sell. Price target $24.

Morgan analyst says, "We are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE